MARY SMITH: Open Payments
NPI 1881183101 · MORRISON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,695 in 111 payments from 11 companies in 2025. Trend: 2023 $1,701 · 2024 $1,625 · 2025 $2,695
Food & beverage: $2,583Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 15 | $527 |
| Teva Pharmaceuticals USA, Inc. | 21 | $486 |
| Alkermes, Inc. | 18 | $359 |
| Neurocrine BioSciences, Inc. | 10 | $293 |
| ABBVIE INC. | 10 | $250 |
| Axsome Therapeutics, Inc. | 7 | $220 |
| Otsuka America Pharmaceutical, Inc. | 14 | $216 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $144 |
| Janssen Pharmaceuticals, Inc | 4 | $119 |
| Lundbeck LLC | 3 | $60 |
Products named: COBENFY, INGREZZA, AUSTEDO XR, ARISTADA, VRAYLAR, Auvelity, REXULTI, CAPLYTA.
Industry payments across TN — which companies pay providers there.
